Cargando…

Evolution of Immune Checkpoint Blockade–Induced Myocarditis Over 2 Years

Ipilimumab and nivolumab for melanoma induced smoldering myocarditis remitting with steroids. Rechallenge with nivolumab produced steroid-refractory myocarditis confirmed by electron microscopy. Tacrolimus and mycophenolate transiently reduced inflammation, but antithymocyte globulin induced remissi...

Descripción completa

Detalles Bibliográficos
Autores principales: Norwood, Timothy G., Lenneman, Carrie A., Westbrook, Brian C., Litovsky, Silvio H., McKee, Svetlana B., Conry, Robert M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298699/
https://www.ncbi.nlm.nih.gov/pubmed/34317205
http://dx.doi.org/10.1016/j.jaccas.2019.11.076
_version_ 1783726113155973120
author Norwood, Timothy G.
Lenneman, Carrie A.
Westbrook, Brian C.
Litovsky, Silvio H.
McKee, Svetlana B.
Conry, Robert M.
author_facet Norwood, Timothy G.
Lenneman, Carrie A.
Westbrook, Brian C.
Litovsky, Silvio H.
McKee, Svetlana B.
Conry, Robert M.
author_sort Norwood, Timothy G.
collection PubMed
description Ipilimumab and nivolumab for melanoma induced smoldering myocarditis remitting with steroids. Rechallenge with nivolumab produced steroid-refractory myocarditis confirmed by electron microscopy. Tacrolimus and mycophenolate transiently reduced inflammation, but antithymocyte globulin induced remission. Cardiomyopathy with fatty infiltration ensued, but the patient succumbed to rampant melanoma progression after lymphocyte depletion. (Level of Difficulty: Advanced.)
format Online
Article
Text
id pubmed-8298699
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-82986992021-07-26 Evolution of Immune Checkpoint Blockade–Induced Myocarditis Over 2 Years Norwood, Timothy G. Lenneman, Carrie A. Westbrook, Brian C. Litovsky, Silvio H. McKee, Svetlana B. Conry, Robert M. JACC Case Rep Mini-Focus Issue: Myocardial and Pericardial Inflammation Ipilimumab and nivolumab for melanoma induced smoldering myocarditis remitting with steroids. Rechallenge with nivolumab produced steroid-refractory myocarditis confirmed by electron microscopy. Tacrolimus and mycophenolate transiently reduced inflammation, but antithymocyte globulin induced remission. Cardiomyopathy with fatty infiltration ensued, but the patient succumbed to rampant melanoma progression after lymphocyte depletion. (Level of Difficulty: Advanced.) Elsevier 2020-02-19 /pmc/articles/PMC8298699/ /pubmed/34317205 http://dx.doi.org/10.1016/j.jaccas.2019.11.076 Text en © 2020 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Mini-Focus Issue: Myocardial and Pericardial Inflammation
Norwood, Timothy G.
Lenneman, Carrie A.
Westbrook, Brian C.
Litovsky, Silvio H.
McKee, Svetlana B.
Conry, Robert M.
Evolution of Immune Checkpoint Blockade–Induced Myocarditis Over 2 Years
title Evolution of Immune Checkpoint Blockade–Induced Myocarditis Over 2 Years
title_full Evolution of Immune Checkpoint Blockade–Induced Myocarditis Over 2 Years
title_fullStr Evolution of Immune Checkpoint Blockade–Induced Myocarditis Over 2 Years
title_full_unstemmed Evolution of Immune Checkpoint Blockade–Induced Myocarditis Over 2 Years
title_short Evolution of Immune Checkpoint Blockade–Induced Myocarditis Over 2 Years
title_sort evolution of immune checkpoint blockade–induced myocarditis over 2 years
topic Mini-Focus Issue: Myocardial and Pericardial Inflammation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298699/
https://www.ncbi.nlm.nih.gov/pubmed/34317205
http://dx.doi.org/10.1016/j.jaccas.2019.11.076
work_keys_str_mv AT norwoodtimothyg evolutionofimmunecheckpointblockadeinducedmyocarditisover2years
AT lennemancarriea evolutionofimmunecheckpointblockadeinducedmyocarditisover2years
AT westbrookbrianc evolutionofimmunecheckpointblockadeinducedmyocarditisover2years
AT litovskysilvioh evolutionofimmunecheckpointblockadeinducedmyocarditisover2years
AT mckeesvetlanab evolutionofimmunecheckpointblockadeinducedmyocarditisover2years
AT conryrobertm evolutionofimmunecheckpointblockadeinducedmyocarditisover2years